Borrelli E, Grosso D, Vella G, et al. - Researchers sought to quantify the influence of delayed care during the coronavirus disease 2019 (COVID-19) pandemic on the outcomes of patients with neovascular age-related macular degeneration (AMD). They consecutively enrolled 100 patients (112 eyes) with diagnosis of neovascular AMD between March 9, 2020, and June 12, 2020, (during and immediately after the Italian COVID-19 quarantine). During the inclusion (or pandemic) visit (V0), patients underwent a complete ophthalmologic evaluation, including optical coherence tomography (OCT). Comparison was performed of best-corrected visual acuity (BCVA) and OCT findings from the two preceding visits (V−1 and V−2) with data at V0. In multiple regression analysis, they noted the difference in BCVA between V0 and V−1 visits to be significantly linked with the interval time within these two visits. Observations revealed that the COVID-19 pandemic resulted in a significant delay in neovascular AMD patient care in a tertiary referral retina unit. Importantly, this postponement was identified to be significantly linked with worse short-term outcomes in these patients.